Details of Drug

Details of Drug

 Drug General Information (ID: D1877)
  Drug Name
Regadenoson
  Drug Type Small molecule
  Drug Synonymous
Lexiscan (TN)
    Click to Show/Hide
  Therapeutic Class Diagnostic Agents
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C15H18N8O5
  InChI 1S/C15H18N8O5/c1-17-13(27)6-2-19-23(3-6)15-20-11(16)8-12(21-15)22(5-18-8)14-10(26)9(25)7(4-24)28-14/h2-3,5,7,9-10,14,24-26H,4H2,1H3,(H,17,27)(H2,16,20,21)/t7-,9-,10-,14-/m1/s1
  InChIKey LZPZPHGJDAGEJZ-AKAIJSEGSA-N
  Canonical SMILES CNC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N
  External Link
Pubchem ID 219024
CAS Number CAS 313348-27-5
CHEBI ID CHEBI:135613
TTD ID D0XE1C

Drug-Drug Interaction Network
  Sunburst Graph
AM007  Pharmacodynamic antagonistic effects
BM107  Attenuated pharmacological effects (Unspecific)
  Relation Graph
 Full list of drugs interacting with Regadenoson
      Pharmacodynamic antagonistic effects
   Attenuated pharmacological effects (Unspecific) Drug Num:  5
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0064
 
Aminophylline
 
C16H24N10O4
 
9433 
Moderate    Inter Info   
[1], [2], [3]
D0231
 
Caffeine
 
C8H10N4O2
 
2519 
Moderate    Inter Info   
[1], [2], [3]
D0544
 
Dyphylline
 
C10H14N4O4
 
3182 
Moderate    Inter Info   
[1], [2], [3]
D1201
 
Oxtriphylline
 
C12H21N5O3
 
656652 
Moderate    Inter Info   
[1], [2], [3]
D1570
 
Theophylline
 
C7H8N4O2
 
2153 
Moderate    Inter Info   
[1], [2], [3]
References
1 Product Information. Persantine (dipyridamole). Boehringer-Ingelheim, Ridgefield, CT.
2 Ranhosky A, Kempthorne-Rawson J, the Intravenous Dipyridamole Thallium Imaging Study Group "The safety of intravenous dipyridamole thallium myocardial perfusion imaging." Circulation 81 (1990): 1205-9. [PMID: 2107985]
3 Smits P, Schouten J, Thien T "Respiratory stimulant effects of adenosine in man after caffeine and enprofylline." Br J Clin Pharmacol 24 (1987): 816-9. [PMID: 3440102]